Neuroprotective role of VEGF induced in response to photodynamic therapy

Yoko Ozawa, Misa Suzuki, Serina Niikura, Mamoru Kamoshita, Norihiro Nagai, Kazuo Tsubota

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Age-related macular degeneration (AMD) is a vision-threatening disease, and its prevalence is increasing worldwide. Two approaches are commonly used to suppress the pathological choroidal neovascularization (CNV) that characterizes 'wet' AMD. One is photodynamic therapy (PDT), which involves using a systemic photosensitizer in combination with low-power laser irradiation of CNV through the neural retina and retinal pigment epithelium (RPE); the other involves the intravitreous injection of drugs targeting vascular endothelial growth factor (VEGF). In some cases, both methods are used simultaneously. However, recent results from animal experiments indicate that transient increase in VEGF in the tissue following PDT is required for retinal cell survival in overcoming the cellular stress caused by PDT. To maximize the visual outcome and retinal protection, it will be necessary to optimize the combination therapy, which requires the elucidation of the molecular and cellular changes that occur in the retinal tissue during the course of treatment.

Original languageEnglish
Pages (from-to)161-165
Number of pages5
JournalAdvances in Neuroimmune Biology
Volume4
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Photochemotherapy
Vascular Endothelial Growth Factor A
Choroidal Neovascularization
Macular Degeneration
Pathologic Neovascularization
Photosensitizing Agents
Retinal Pigment Epithelium
Drug Delivery Systems
Retina
Cell Survival
Injections
Therapeutics

Keywords

  • AKT
  • neuron
  • retina
  • VEGF

ASJC Scopus subject areas

  • Immunology
  • Endocrine and Autonomic Systems
  • Endocrinology

Cite this

Neuroprotective role of VEGF induced in response to photodynamic therapy. / Ozawa, Yoko; Suzuki, Misa; Niikura, Serina; Kamoshita, Mamoru; Nagai, Norihiro; Tsubota, Kazuo.

In: Advances in Neuroimmune Biology, Vol. 4, No. 3, 2013, p. 161-165.

Research output: Contribution to journalArticle

@article{72eb0242c6bc4996bac93a3ae6957b6b,
title = "Neuroprotective role of VEGF induced in response to photodynamic therapy",
abstract = "Age-related macular degeneration (AMD) is a vision-threatening disease, and its prevalence is increasing worldwide. Two approaches are commonly used to suppress the pathological choroidal neovascularization (CNV) that characterizes 'wet' AMD. One is photodynamic therapy (PDT), which involves using a systemic photosensitizer in combination with low-power laser irradiation of CNV through the neural retina and retinal pigment epithelium (RPE); the other involves the intravitreous injection of drugs targeting vascular endothelial growth factor (VEGF). In some cases, both methods are used simultaneously. However, recent results from animal experiments indicate that transient increase in VEGF in the tissue following PDT is required for retinal cell survival in overcoming the cellular stress caused by PDT. To maximize the visual outcome and retinal protection, it will be necessary to optimize the combination therapy, which requires the elucidation of the molecular and cellular changes that occur in the retinal tissue during the course of treatment.",
keywords = "AKT, neuron, retina, VEGF",
author = "Yoko Ozawa and Misa Suzuki and Serina Niikura and Mamoru Kamoshita and Norihiro Nagai and Kazuo Tsubota",
year = "2013",
doi = "10.3233/NIB-130062",
language = "English",
volume = "4",
pages = "161--165",
journal = "Advances in Neuroimmune Biology",
issn = "1878-948X",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Neuroprotective role of VEGF induced in response to photodynamic therapy

AU - Ozawa, Yoko

AU - Suzuki, Misa

AU - Niikura, Serina

AU - Kamoshita, Mamoru

AU - Nagai, Norihiro

AU - Tsubota, Kazuo

PY - 2013

Y1 - 2013

N2 - Age-related macular degeneration (AMD) is a vision-threatening disease, and its prevalence is increasing worldwide. Two approaches are commonly used to suppress the pathological choroidal neovascularization (CNV) that characterizes 'wet' AMD. One is photodynamic therapy (PDT), which involves using a systemic photosensitizer in combination with low-power laser irradiation of CNV through the neural retina and retinal pigment epithelium (RPE); the other involves the intravitreous injection of drugs targeting vascular endothelial growth factor (VEGF). In some cases, both methods are used simultaneously. However, recent results from animal experiments indicate that transient increase in VEGF in the tissue following PDT is required for retinal cell survival in overcoming the cellular stress caused by PDT. To maximize the visual outcome and retinal protection, it will be necessary to optimize the combination therapy, which requires the elucidation of the molecular and cellular changes that occur in the retinal tissue during the course of treatment.

AB - Age-related macular degeneration (AMD) is a vision-threatening disease, and its prevalence is increasing worldwide. Two approaches are commonly used to suppress the pathological choroidal neovascularization (CNV) that characterizes 'wet' AMD. One is photodynamic therapy (PDT), which involves using a systemic photosensitizer in combination with low-power laser irradiation of CNV through the neural retina and retinal pigment epithelium (RPE); the other involves the intravitreous injection of drugs targeting vascular endothelial growth factor (VEGF). In some cases, both methods are used simultaneously. However, recent results from animal experiments indicate that transient increase in VEGF in the tissue following PDT is required for retinal cell survival in overcoming the cellular stress caused by PDT. To maximize the visual outcome and retinal protection, it will be necessary to optimize the combination therapy, which requires the elucidation of the molecular and cellular changes that occur in the retinal tissue during the course of treatment.

KW - AKT

KW - neuron

KW - retina

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=84896763000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896763000&partnerID=8YFLogxK

U2 - 10.3233/NIB-130062

DO - 10.3233/NIB-130062

M3 - Article

VL - 4

SP - 161

EP - 165

JO - Advances in Neuroimmune Biology

JF - Advances in Neuroimmune Biology

SN - 1878-948X

IS - 3

ER -